Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Harvard Business School
Daiichi Sankyo
Johnson and Johnson

Generated: April 21, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022332

« Back to Dashboard

NDA 022332 describes ADCIRCA, which is a drug marketed by Eli Lilly Co and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ADCIRCA profile page.

The generic ingredient in ADCIRCA is tadalafil. There are twenty-five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 022332
Applicant:Eli Lilly Co
Formulation / Manufacturing:see details
Pharmacology for NDA: 022332
Medical Subject Heading (MeSH) Categories for 022332
Suppliers and Packaging for NDA: 022332
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADCIRCA tadalafil TABLET;ORAL 022332 NDA Aphena Pharma Solutions - Tennessee, LLC 43353-070 43353-070-12 12 TABLET in 1 BOTTLE (43353-070-12)
ADCIRCA tadalafil TABLET;ORAL 022332 NDA United Therapeutics Corporation 66302-467 66302-467-60 60 TABLET in 1 BOTTLE (66302-467-60)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:May 22, 2009TE:AB2RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 19, 2021Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:Oct 26, 2020Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Harvard Business School
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.